Stay updated on Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.

Latest updates to the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page
- Check7 days agoChange DetectedThe page’s version/revision label has been updated from v3.5.2 to v3.5.3, indicating an internal site update rather than a change to the clinical trial record details.SummaryDifference0.1%

- Check14 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0 from the study record history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedThe Record History now shows a new revision entry v3.5.0 and the previous entry v3.4.3 has been removed. No study data or results are changed.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the study record history.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.4.2 was added to the history, and the funding-status notice along with Revision: v3.4.1 were removed.SummaryDifference0.9%

- Check86 days agoChange DetectedA site-wide government funding notice has been added to the top of the page, and the revision history now shows a new Revision: v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.